
|Videos|March 30, 2022
The Utility of Circulating Tumor DNA for Detecting Clinically Evident and Occult MCC
Author(s)Mary Scoviak, Managing Editor
In this first part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, explains the science behind her presentation on "The Utility of Circulating Tumor DNA for Detecting Clinically Evident and Occult Merkel Cell Carcinoma." This was presented at the 2022 American Academy of Dermatology Annual Meeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
How Emerging Androgenetic Alopecia Therapies Target DHT at the Scalp Level
2
Social Media Mythbusters: Beef Tallow
3
The Value of Clinician Collaboration for Skin Cancer Care
4
From Biopsy to Biomarkers: Experts Navigate Skin Cancer Diagnosis and Staging
5







